Insider Trading › CLOV › Insiders
CLOVER HEALTH INVESTMENTS, CORP. /DE
CLOV·Nasdaq·
United States·Insider activity
United States·Insider activity$4.60
-0.08 (-1.71%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
CLOV
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CLOVS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, CLOV insiders filed 0 purchases ($0) and 28 sales ($7.6M) on the open market, by 8 insiders. Newest filing Oct 5, 2026 (2 days ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by CLOV insiders · Form 4 · last two years
On Record
$0Purchases · 180 days
$7.6MSales · 180 days
64Open-market transactions on record
8Insiders filing · 180 days
Purchases (code P) and sales (code S) of CLOV common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
64 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −8,750 | $4.42 | $39K | 2.8Mdirect | Oct 5, 2026 | Oct 5, 2026 | Form 4 ↗ |
| Toy AndrewChief Executive Officer · Director | Sale | −318.8K | $4.19 | $1.3M | 9.1Mdirect | Oct 1, 2026 | Oct 2, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −1,921 | $4.56 | $9K | 2.8Mdirect | Sep 17, 2026 | Sep 18, 2026 | Form 4 ↗ |
| OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER | Sale | −3,170 | $4.64 | $15K | 275.9Kdirect | Sep 16, 2026 | Sep 17, 2026 | Form 4 ↗ |
| Wai ConradCEO, Counterpart Health | Sale | −300.0K | $4.72 | $1.4M | 1.2Mindirect | Sep 15, 2026 | Sep 16, 2026 | Form 4 ↗ |
| Soares KarenChief Legal Officer | Sale | −6,846 | $4.78 | $33K | 1.6Mdirect | Sep 15, 2026 | Sep 15, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −9,273 | $4.78 | $44K | 2.8Mdirect | Sep 15, 2026 | Sep 15, 2026 | Form 4 ↗ |
| OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER | Sale | −20.0K | $5.16 | $103K | 279.1Kdirect | Sep 14, 2026 | Sep 14, 2026 | Form 4 ↗ |
| THORNTON JOSEPH CLAYInterim CFO | Sale | −17.8K | $4.39 | $78K | 1.2Mdirect | Aug 17, 2026 | Aug 17, 2026 | Form 4 ↗ |
| Toy AndrewChief Executive Officer · Director | Sale | −87.8K | $4.65 | $408K | 9.5Mdirect | Aug 10, 2026 | Aug 10, 2026 | Form 4 ↗ |
| Soares KarenChief Legal Officer | Sale | −51.7K | $4.51 | $233K | 1.5Mdirect | Jul 20, 2026 | Jul 20, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −4,839 | $4.53 | $22K | 2.8Mdirect | Jul 17, 2026 | Jul 17, 2026 | Form 4 ↗ |
| Toy AndrewChief Executive Officer · Director | Sale | −62.7K | $4.67 | $293K | 9.5Mdirect | Jul 15, 2026 | Jul 16, 2026 | Form 4 ↗ |
| Wai ConradCEO, Counterpart Health | Sale | −24.2K | $4.67 | $113K | 1.1Mdirect | Jul 15, 2026 | Jul 16, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −13.1K | $4.67 | $61K | 2.8Mdirect | Jul 15, 2026 | Jul 16, 2026 | Form 4 ↗ |
| Soares KarenChief Legal Officer | Sale | −10.5K | $4.67 | $49K | 1.6Mdirect | Jul 15, 2026 | Jul 16, 2026 | Form 4 ↗ |
| THORNTON JOSEPH CLAYInterim CFO | Sale | −4,630 | $4.67 | $22K | 1.2Mdirect | Jul 15, 2026 | Jul 16, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −2,384 | $4.68 | $11K | 2.8Mdirect | Jul 8, 2026 | Jul 9, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −6,229 | $5.26 | $33K | 2.8Mdirect | Jul 6, 2026 | Jul 6, 2026 | Form 4 ↗ |
| Toy AndrewChief Executive Officer · Director | Sale | −313.5K | $5.32 | $1.7M | 9.6Mdirect | Jul 1, 2026 | Jul 1, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −2,360 | $4.78 | $11K | 2.8Mdirect | Jun 17, 2026 | Jun 18, 2026 | Form 4 ↗ |
| OLDAKOWSKI JOSEPH FRANKVP OF FINANCE AND CONTROLLER | Sale | −12.1K | $4.86 | $59K | 299.1Kdirect | Jun 16, 2026 | Jun 17, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −6,350 | $4.61 | $29K | 2.8Mdirect | Jun 15, 2026 | Jun 16, 2026 | Form 4 ↗ |
| Soares KarenChief Legal Officer | Sale | −4,681 | $4.61 | $22K | 1.6Mdirect | Jun 15, 2026 | Jun 16, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −7,289 | $4.91 | $36K | 2.8Mdirect | Jun 11, 2026 | Jun 11, 2026 | Form 4 ↗ |
| Wai ConradCEO, Counterpart Health | Sale | −220.4K | $3.99 | $879K | 1.4Mindirect | May 28, 2026 | May 28, 2026 | Form 4 ↗ |
| Edwards Carladenise ArmbristerDirector | Sale | −67.2K | $3.42 | $230K | 285.4Kdirect | May 18, 2026 | May 19, 2026 | Form 4 ↗ |
| Priest Brady PatrickCEO of Clover Care Services | Sale | −98.0K | $3.52 | $345K | 2.0Mdirect | May 13, 2026 | May 13, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −5,833 | $1.91 | $11K | 2.7Mdirect | Mar 18, 2026 | Mar 18, 2026 | Form 4 ↗ |
| Priest Brady PatrickCEO of Home Care | Sale | −175.0K | $2.17 | $380K | 2.0Mdirect | Mar 4, 2026 | Mar 5, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −4,597 | $2.58 | $12K | 2.7Mdirect | Jan 20, 2026 | Jan 20, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −2,102 | $2.53 | $5K | 2.8Mdirect | Jan 7, 2026 | Jan 7, 2026 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −4,913 | $2.61 | $13K | 2.8Mdirect | Dec 18, 2025 | Dec 18, 2025 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −30.4K | $3.58 | $109K | 2.8Mdirect | Nov 4, 2025 | Nov 5, 2025 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −16.5K | $2.69 | $44K | 3.0Mdirect | Oct 17, 2025 | Oct 21, 2025 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −2,012 | $2.65 | $5K | 3.0Mdirect | Oct 7, 2025 | Oct 7, 2025 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −4,914 | $3.09 | $15K | 3.1Mdirect | Sep 17, 2025 | Sep 19, 2025 | Form 4 ↗ |
| Loengard Anna UDirector | Purchase | +14.5K | $2.59 | $38K | 29.6Kindirect | Aug 13, 2025 | Aug 14, 2025 | Form 4 ↗ |
| Loengard Anna UDirector | Purchase | +12.0K | $2.60 | $31K | 27.6Kindirect | Aug 13, 2025 | Aug 14, 2025 | Form 4 ↗ |
| Garipalli VivekDirector · 10% owner | Purchase | +32.0K | $2.17 | $69K | 1.9Mdirect | Aug 8, 2025 | Aug 8, 2025 | Form 4 ↗ |
| Garipalli VivekDirector · 10% owner | Purchase | +415.0K | $2.24 | $930K | 1.8Mdirect | Aug 7, 2025 | Aug 8, 2025 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −6,823 | $2.89 | $20K | 3.3Mdirect | Aug 4, 2025 | Aug 6, 2025 | Form 4 ↗ |
| Wai ConradCEO, Counterpart Health | Sale | −91.2K | $3.32 | $303K | 1.4Mindirect | Jul 23, 2025 | Jul 24, 2025 | Form 4 ↗ |
| Wai ConradCEO, Counterpart Health | Sale | −118.6K | $3.29 | $390K | 1.5Mindirect | Jul 22, 2025 | Jul 24, 2025 | Form 4 ↗ |
| Wai ConradCEO, Counterpart Health | Sale Amended | −15.2K | $3.26 | $50K | 1.6Mindirect | Jul 8, 2025 | Jul 10, 2025 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −2,012 | $2.85 | $6K | 3.3Mdirect | Jul 7, 2025 | Jul 8, 2025 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −19.8K | $2.58 | $51K | 3.3Mdirect | Jul 3, 2025 | Jul 8, 2025 | Form 4 ↗ |
| Reynoso Jamie L.CEO, Medicare Advantage | Sale | −20.4K | $2.86 | $58K | 3.2Mdirect | Jun 17, 2025 | Jun 18, 2025 | Form 4 ↗ |
| Edwards Carladenise ArmbristerDirector | Sale | −200.0K | $3.61 | $722K | 273.2Kdirect | Mar 7, 2025 | Mar 11, 2025 | Form 4 ↗ |
| Priest Brady PatrickCEO of Home Care | Sale | −75.0K | $3.68 | $276K | 2.4Mdirect | Mar 6, 2025 | Mar 7, 2025 | Form 4 ↗ |
| Soares KarenGeneral Counsel & Secretary | Sale | −52.5K | $3.80 | $200K | 1.3Mdirect | Mar 6, 2025 | Mar 7, 2025 | Form 4 ↗ |
| Garipalli VivekDirector · 10% owner | Purchase | +531.7K | $1.88 | $1.0M | 1.4Mdirect | Aug 9, 2024 | Aug 13, 2024 | Form 4 ↗ |
| Garipalli VivekDirector · 10% owner | Purchase | +877.6K | $1.14 | $1.0M | 877.6Kdirect | Jun 17, 2024 | Jun 20, 2024 | Form 4 ↗ |
| Loengard Anna UDirector | Purchase | +10.0K | $0.93 | $9K | 10.0Kindirect | May 17, 2024 | May 20, 2024 | Form 4 ↗ |
| Loengard Anna UDirector | Purchase | +1,485 | $0.94 | $1K | 15.1Kindirect | May 16, 2024 | May 20, 2024 | Form 4 ↗ |
| Loengard Anna UDirector | Purchase | +15.6K | $0.96 | $15K | 15.6Kindirect | May 16, 2024 | May 20, 2024 | Form 4 ↗ |
| Loengard Anna UDirector | Purchase | +13.6K | $0.73 | $10K | 15.1Kindirect | Mar 14, 2024 | Mar 18, 2024 | Form 4 ↗ |
| Loengard Anna UDirector | Purchase | +137.0K | $0.73 | $100K | 538.8Kdirect | Mar 14, 2024 | Mar 18, 2024 | Form 4 ↗ |
| Loengard Anna UDirector | Purchase | +500 | $1.30 | $650 | 1,500indirect | Sep 6, 2023 | Sep 8, 2023 | Form 4 ↗ |
| Loengard Anna UDirector | Purchase | +500 | $1.30 | $650 | 1,300indirect | Sep 6, 2023 | Sep 8, 2023 | Form 4 ↗ |
| Loengard Anna UDirector | Purchase | +10.0K | $1.30 | $13K | 10.0Kindirect | Sep 6, 2023 | Sep 8, 2023 | Form 4 ↗ |
| SHAPIRO LEEDirector | Purchase | +80.0K | $3.10 | $248K | 107.1Kdirect | Mar 11, 2022 | Mar 15, 2022 | Form 4 ↗ |
| Clinton ChelseaDirector | Purchase | +100.0K | $2.53 | $253K | 100.0Kdirect | Mar 3, 2022 | Mar 4, 2022 | Form 4 ↗ |
| SCH Sponsor III LLC10% owner | Purchase | +1.7M | $5.75 | $10.0M | 1.7Mindirect | Nov 22, 2021 | Nov 24, 2021 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →